Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stem Pharm
Madison, Wisconsin, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Stem Pharm has developed proprietary human stem cell–derived 3D neural organoids with integrated microglia on chemically defined hydrogels, used for preclinical disease modeling, target discovery, phenotypic screening, and neurotoxicity testing in neurodegenerative disease, epilepsy, brain tumors, and other neuroinflammatory indications.[1][2][3] The company has multiple NIH SBIR/STTR grants (including Alzheimer’s disease and glioblastoma models) and collaborations with pharma/biotech but has not yet advanced its own therapeutic candidates into clinical trials.[2][3]
- Therapeutic areas
- OncologyNeurology
- Modalities
- Stem cell therapyInduced pluripotent stem cell derived therapyHydrogel-based drug delivery therapyBiologic
- Industry
- Non-Drug Biotech
02
Partnerships
Verge Genomics (Parkinson’s disease model development collaboration)[2]Multiple biopharma partners for neurologic disease modeling and drug discovery services (not individually named)[1][2][3]National Institutes of Health (NIH) SBIR/STTR grant-supported collaborations including NCI STTR for glioblastoma with UW–Madison investigators[2]
Beyond the preview
Go deeper on Stem Pharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Stem Pharm.